Literature DB >> 19877805

A modified far-lateral approach for large or giant meningiomas of the posterior fossa.

Nader Sanai1, Michael W McDermott.   

Abstract

OBJECT: Resecting large meningiomas along the posterior fossa convexity or cerebellopontine angle (CPA) through a suboccipital approach can be challenging. Limitations include a restricted angle of view, high venous pressures, and suboptimal brain relaxation. While a far-lateral craniotomy is a viable alternative, the risks associated with condylar resection are undesirable.
METHODS: The authors retrospectively evaluated a modified far-lateral approach in a consecutive series of 12 patients with large or giant posterior fossa convexity and CPA meningiomas. This approach incorporates transverse-sigmoid sinus exposure and C-1 laminectomy, but there is no condylar resection.
RESULTS: Between January 2006 and February 2008, 12 patients (mean age 52 years) presented with large or giant meningiomas of the posterior fossa convexity or CPA. The mean tumor volume was 72.6 cm3 (range 8-131 cm3). Signs and symptoms at presentation included headache (in 8 patients), cranial neuropathy (in 4), and progressive hemiparesis (in 4). There were no operative complications, and the majority of patients (9) had Simpson Grade I or II resections. There were no new permanent neurological deficits following resection, although 2 patients (17%) had transient deficits. The mean modified Rankin score decreased from 2.2 preoperatively to 0.6 postoperatively.
CONCLUSIONS: A modified far-lateral approach to the posterior fossa and CPA allows for safe, and often total, resection of large meningiomas with minimal morbidity. While avoiding the risks of condylar resection, this microsurgical strategy allows for greater field of view, minimal venous bleeding, and immediate access to the spinal subarachnoid space.

Entities:  

Mesh:

Year:  2010        PMID: 19877805     DOI: 10.3171/2009.6.JNS09120

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  7 in total

1.  Extended Retrosigmoid Approach for Cerebellopontine Angle Meningiomas: Operative Technique and Results-A Series of 28 Patients.

Authors:  Jose Carlos Lynch; Celestino Pereira; Leonardo Welling; Mariangela Gonçalves; Nelci Zanon
Journal:  J Neurol Surg B Skull Base       Date:  2018-01-18

2.  Quantitative Anatomical Study of Tailored Far-Lateral Approach for the VA-PICA Regions.

Authors:  Young-Don Kim; George A C Mendes; Pablo Seoane; Abhishek Agrawal; Naveen Maramreddy; Peter Nakaji; Robert F Spetzler; Mark C Preul
Journal:  J Neurol Surg B Skull Base       Date:  2014-09-21

3.  Giant posterior fossa meningioma: the importance of early diagnosis and challenges concerning treatment.

Authors:  Cristiano Antunes; Rui Ramos; Maria João Machado; Miguel Afonso Filipe
Journal:  BMJ Case Rep       Date:  2019-03-20

4.  Surgical Outcomes, Complications, and Management Strategies for Foramen Magnum Meningiomas.

Authors:  Stephen T Magill; Maryam N Shahin; Calixto-Hope G Lucas; Adam J Yen; David S Lee; David R Raleigh; Manish K Aghi; Philip V Theodosopoulos; Michael W McDermott
Journal:  J Neurol Surg B Skull Base       Date:  2018-05-28

5.  Far Lateral Craniotomy Closure Technique for Preservation of Suboccipital Musculature.

Authors:  Muhammad Salman Ali; Stephen T Magill; Michael W McDermott
Journal:  J Neurol Surg B Skull Base       Date:  2020-08-20

6.  The Surgical Risk Factors of Giant Intracranial Meningiomas: A Multi-Centric Retrospective Analysis of Large Case Serie.

Authors:  Daniele Armocida; Antonia Catapano; Mauro Palmieri; Umberto Aldo Arcidiacono; Alessandro Pesce; Fabio Cofano; Veronica Picotti; Maurizio Salvati; Diego Garbossa; Giancarlo D'Andrea; Antonio Santoro; Alessandro Frati
Journal:  Brain Sci       Date:  2022-06-22

7.  Surgical Management and Outcome Experience of 53 Cerebellopontine Angle Meningiomas.

Authors:  Xiaosheng He; Weiping Liu; Yangang Wang; Jun Zhang; Buqing Liang; Jason H Huang
Journal:  Cureus       Date:  2017-08-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.